Top

Published in:

01-08-2020 | Editorial

Motion correction to enhance absolute myocardial blood flow quantitation by PET

Authors: John R. Votaw, PhD, René R. Sevag Packard, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 4/2020

Excerpt

In this issue of the Journal of Nuclear Cardiology, Poitrasson-Rivière et al propose that automated motion correction followed by technologist manual adjustment reduces inter-user variability in the assessment of positron-emission tomography (PET)-derived absolute myocardial blood flow (MBF) and myocardial flow reserve (MFR).1 We will highlight the importance of PET MFR assessment, provide an overview of issues related to motion and suggested corrections, discuss essential features of the article, and propose future directions. …

Poitrasson-Rivière A, Moody JB, Hagio T, Weinberg RL, Corbett JR, Murthy VL. Reducing motion-correction-induced variability in 82Rubidium myocardial blood flow quantification. J Nucl Cardiol, in press.

Ziadi MC, Dekemp RA, Williams KA, Guo A, Chow BJ, Renaud JM, et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58:740–8.CrossRef

Murthy VL, Naya M, Foster CR, Hainer J, Gaber M, Di Carli G, et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation. 2011;124:2215–24.CrossRef

Murthy VL, Naya M, Foster CR, Gaber M, Hainer J, Klein J, et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation. 2012;126:1858–979.CrossRef

Shah NR, Charytan DM, Murthy VL, Skali Lami H, Veeranna V, Cheezum MK, et al. Prognostic value of coronary flow reserve in patients with dialysis-dependent ESRD. J Am Soc Nephrol. 2016;27:1823–9.CrossRef

Taqueti VR, Shaw LJ, Cook NR, Murthy VL, Shah NR, Foster CR, et al. Excess cardiovascular risk in women relative to men referred for coronary angiography is associated with severely impaired coronary flow reserve, not obstructive disease. Circulation. 2017;135:566–77.CrossRef

Taqueti VR, Solomon SD, Shah AM, Desai AS, Groarke JD, Osborne MT, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018;39:840–9.CrossRef

Taqueti VR, Hachamovitch R, Murthy VL, Naya M, Foster CR, Hainer J, et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation. 2015;131:19–27.CrossRef

Patel KK, Spertus JA, Chan PS, Sperry BW, Al Badarin F, Kennedy KF, et al. Myocardial blood flow reserve assessed by positron emission tomography myocardial perfusion imaging identifies patients with a survival benefit from early revascularization. Eur Heart J. 2019. https://doi.org/10.1093/eurheartj/ehz389.CrossRefPubMedPubMedCentral

10.

Bajaj NS, Osborne MT, Gupta A, Tavakkoli A, Bravo PE, Vita T, et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients. J Am Coll Cardiol. 2018;72:707–17.CrossRef

11.

Murthy VL, Bateman TM, Beanlands RS, Berman DS, Borges-Neto S, Chareonthaitawee P, et al. Clinical quantification of myocardial blood flow using PET: Joint position paper of the SNMMI cardiovascular council and the ASNC. J Nucl Cardiol. 2018;25:269–97.CrossRef

12.

13.

Piccinelli M, Votaw JR, Garcia EV. Motion correction and its impact on absolute myocardial blood flow measures with PET. Curr Cardiol Rep. 2018;20:34.CrossRef

14.

Gould KL, Pan T, Loghin C, Johnson NP, Guha A, Sdringola S. Frequent diagnostic errors in cardiac PET/CT due to misregistration of CT attenuation and emission PET images: A definitive analysis of causes, consequences, and corrections. J Nucl Med. 2007;48:1112–21.CrossRef

15.

Rajaram M, Tahari AK, Lee AH, Lodge MA, Tsui B, Nekolla S, et al. Cardiac PET/CT misregistration causes significant changes in estimated myocardial blood flow. J Nucl Med. 2013;54:50–4.CrossRef

16.

Friedman J, Van Train K, Maddahi J, Rozanski A, Prigent F, Bietendorf J, et al. “Upward creep” of the heart: a frequent source of false-positive reversible defects during thallium-201 stress-redistribution SPECT. J Nucl Med. 1989;30:1718–22.PubMed

17.

Votaw JR, Packard RRS. Technical aspects of acquiring and measuring myocardial blood flow: Method, technique, and QA. J Nucl Cardiol. 2018;25:665–70.CrossRef

18.

Koenders SS, van Dijk JD, Jager PL, Ottervanger JP, Slump CH, van Dalen JA. Impact of regadenoson-induced myocardial creep on dynamic Rubidium-82 PET myocardial blood flow quantification. J Nucl Cardiol. 2019;26:719–28.CrossRef

19.

Berman DS, Germano G, Slomka PJ. Improvement in PET myocardial perfusion image quality and quantification with flurpiridaz F 18. J Nucl Cardiol. 2012;19(Suppl 1):S38–45.CrossRef

20.

Rubeaux M, Doris MK, Alessio A, Slomka PJ. Enhancing cardiac PET by motion correction techniques. Curr Cardiol Rep. 2017;19:14.CrossRef

21.

Yu YH, Chan C, Ma TY, Liu YQ, Gallezot JD, Naganawa M, et al. Event-by-event continuous respiratory motion correction for dynamic PET imaging. J Nucl Med. 2016;57:1084–90.CrossRef

22.

Lee BC, Moody JB, Poitrasson-Rivière A, Melvin AC, Weinberg RL, Corbett JR, et al. Automated dynamic motion correction using normalized gradient fields for ⁸²Rubidium PET myocardial blood flow quantification. J Nucl Cardiol. 2018. https://doi.org/10.1007/s12350-018-01471-4.CrossRefPubMedPubMedCentral

23.

Lu Y, Liu C. Patient motion correction for dynamic cardiac PET: Current status and challenges. J Nucl Cardiol. 2018. https://doi.org/10.1007/s12350-018-01513-x.CrossRefPubMed

24.

Hunter CR, Klein R, Beanlands RS, deKemp RA. Patient motion effects on the quantification of regional myocardial blood flow with dynamic PET imaging. Med Phys. 2016;43:1829.CrossRef

25.

Woo J, Tamarappoo B, Dey D, Nakazato R, Le Meunier L, Ramesh A, et al. Automatic 3D registration of dynamic stress and rest (82)Rb and flurpiridaz F 18 myocardial perfusion PET data for patient motion detection and correction. Med Phys. 2011;38:6313–26.CrossRef

26.

Gould KL, Johnson NP, Bateman TM, Beanlands RS, Bengel FM, Bober R et al. Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 2013;62:1639-53.

27.

Johnson NP, Gould KL. Fractional flow reserve returns to its origins: Quantitative cardiac positron emission tomography. Circ Cardiovasc Imaging 2016;9:e005435

28.

Merlet P, Mazoyer B, Hittinger L, Valette H, Saal JP, Bendriem B, et al. Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique. J Nucl Med. 1993;34:1899–904.PubMed

29.

Gaster AL, Korsholm L, Thayssen P, Pedersen KE, Haghfelt TH. Reproducibility of intravascular ultrasound and intracoronary Doppler measurements. Catheter Cardiovasc Interv. 2001;53:449–58.CrossRef

30.

Nagamachi S, Czernin J, Kim AS, Sun KT, Bottcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med. 1996;37:1626–31.PubMed

31.

Schindler TH, Zhang XL, Prior JO, Cadenas J, Dahlbom M, Sayre J, et al. Assessment of intra- and interobserver reproducibility of rest and cold pressor test-stimulated myocardial blood flow with (13)N-ammonia and PET. Eur J Nucl Med Mol Imaging. 2007;34:1178–88.CrossRef

32.

Kitkungvan D, Johnson NP, Roby AE, Patel MB, Kirkeeide R, Gould KL. Routine clinical quantitative rest stress myocardial perfusion for managing coronary artery disease: Clinical relevance of test-retest variability. J Am Coll Cardiol Cardiovasc Imaging. 2017;10:565–77.CrossRef

Title: Motion correction to enhance absolute myocardial blood flow quantitation by PET
Authors: John R. Votaw, PhD
René R. Sevag Packard, MD, PhD
Publication date: 01-08-2020
Publisher: Springer International Publishing
Published in: Journal of Nuclear Cardiology / Issue 4/2020
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-019-01912-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Motion correction to enhance absolute myocardial blood flow quantitation by PET

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2020

Cardiovascular disease in the literature: A selection of recent original research papers

Duration of proton pump inhibitor abstinence before myocardial perfusion scintigraphy

Exercise stress testing: Time to restart in nuclear cardiology?

Clinical effectiveness of an outpatient pathway for low-risk chest pain emergency department visits

A quick glance at selected topics in this issue

Striving for consistency in the measurement of LVEF and left ventricular volume

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page